A Review of FDA’s Action Plan to Proactively Reduce Prescription Opioid Abuse

Current Edition

A Review of FDA’s Action Plan to Proactively Reduce Prescription Opioid Abuse

The increasing rates of opioid abuse and dependence, as well as
the alarming rise in the number of prescription opioid-related
overdoses and deaths in the US, has caused government
agencies around the globe to launch various initiatives in an
attempt to stem the tide of this devastating public health
crisis. Henry Riordan at Worldwide Clinical Trials reviews the
FDA’s Action Plan to Proactively Reduce Prescription Opioid
Abuse.

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.